Go Pro

RTW Biotech Opportunities (RTW) Competitors

RTW Biotech Opportunities logo
GBX 2.36 +0.04 (+1.72%)
As of 12:39 PM Eastern

RTW vs. VSL, RSE, CIP, PGIT, and DNE

Should you buy RTW Biotech Opportunities stock or one of its competitors? RTW Biotech Opportunities's main competitors and comparable companies include VPC Specialty Lending Investments (VSL), Riverstone Energy (RSE), CIP Merchant Capital (CIP), Premier Global Infrastructure Trust PLC (PGIT.L) (PGIT), and Dunedin Enterprise Investment Trust (DNE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does RTW Biotech Opportunities compare to VPC Specialty Lending Investments?

RTW Biotech Opportunities (LON:RTW) and VPC Specialty Lending Investments (LON:VSL) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

In the previous week, RTW Biotech Opportunities had 1 more articles in the media than VPC Specialty Lending Investments. MarketBeat recorded 2 mentions for RTW Biotech Opportunities and 1 mentions for VPC Specialty Lending Investments. VPC Specialty Lending Investments' average media sentiment score of 0.75 beat RTW Biotech Opportunities' score of 0.19 indicating that VPC Specialty Lending Investments is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RTW Biotech Opportunities
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
VPC Specialty Lending Investments
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

RTW Biotech Opportunities has a net margin of 158.61% compared to VPC Specialty Lending Investments' net margin of 108.11%. RTW Biotech Opportunities' return on equity of 36.01% beat VPC Specialty Lending Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
VPC Specialty Lending Investments 108.11%-46.94%-3.93%

RTW Biotech Opportunities has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, VPC Specialty Lending Investments has a beta of 0.304, indicating that its share price is 70% less volatile than the broader market.

RTW Biotech Opportunities has higher revenue and earnings than VPC Specialty Lending Investments. VPC Specialty Lending Investments is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
VPC Specialty Lending Investments-£31.41M-0.91-£31.27M-£11.87N/A

2.8% of RTW Biotech Opportunities shares are owned by institutional investors. Comparatively, 22.1% of VPC Specialty Lending Investments shares are owned by institutional investors. 0.6% of RTW Biotech Opportunities shares are owned by insiders. Comparatively, 0.3% of VPC Specialty Lending Investments shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

RTW Biotech Opportunities beats VPC Specialty Lending Investments on 11 of the 13 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Riverstone Energy?

RTW Biotech Opportunities (LON:RTW) and Riverstone Energy (LON:RSE) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

In the previous week, RTW Biotech Opportunities had 2 more articles in the media than Riverstone Energy. MarketBeat recorded 2 mentions for RTW Biotech Opportunities and 0 mentions for Riverstone Energy. RTW Biotech Opportunities' average media sentiment score of 0.19 beat Riverstone Energy's score of 0.00 indicating that RTW Biotech Opportunities is being referred to more favorably in the media.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
Riverstone Energy Neutral

2.8% of RTW Biotech Opportunities shares are held by institutional investors. Comparatively, 7.5% of Riverstone Energy shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by company insiders. Comparatively, 66.9% of Riverstone Energy shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

RTW Biotech Opportunities has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, Riverstone Energy has a beta of 0.14201292, indicating that its share price is 86% less volatile than the broader market.

RTW Biotech Opportunities has a net margin of 158.61% compared to Riverstone Energy's net margin of -1.67%. RTW Biotech Opportunities' return on equity of 36.01% beat Riverstone Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
Riverstone Energy -1.67%-3.23%-0.22%

RTW Biotech Opportunities has higher revenue and earnings than Riverstone Energy. Riverstone Energy is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Riverstone Energy£26.25M1.07£78.63M-£8.84N/A

Summary

RTW Biotech Opportunities beats Riverstone Energy on 9 of the 13 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to CIP Merchant Capital?

CIP Merchant Capital (LON:CIP) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

In the previous week, RTW Biotech Opportunities had 2 more articles in the media than CIP Merchant Capital. MarketBeat recorded 2 mentions for RTW Biotech Opportunities and 0 mentions for CIP Merchant Capital. RTW Biotech Opportunities' average media sentiment score of 0.19 beat CIP Merchant Capital's score of 0.00 indicating that RTW Biotech Opportunities is being referred to more favorably in the news media.

Company Overall Sentiment
CIP Merchant Capital Neutral
RTW Biotech Opportunities Neutral

RTW Biotech Opportunities has higher revenue and earnings than CIP Merchant Capital. CIP Merchant Capital is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CIP Merchant Capital£8.87M0.00N/A£13.70N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 0.6% of RTW Biotech Opportunities shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

RTW Biotech Opportunities has a net margin of 158.61% compared to CIP Merchant Capital's net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat CIP Merchant Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
CIP Merchant CapitalN/A N/A N/A
RTW Biotech Opportunities 158.61%36.01%-0.47%

Summary

RTW Biotech Opportunities beats CIP Merchant Capital on 8 of the 10 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Premier Global Infrastructure Trust PLC (PGIT.L)?

RTW Biotech Opportunities (LON:RTW) and Premier Global Infrastructure Trust PLC (PGIT.L) (LON:PGIT) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

In the previous week, RTW Biotech Opportunities had 2 more articles in the media than Premier Global Infrastructure Trust PLC (PGIT.L). MarketBeat recorded 2 mentions for RTW Biotech Opportunities and 0 mentions for Premier Global Infrastructure Trust PLC (PGIT.L). RTW Biotech Opportunities' average media sentiment score of 0.19 beat Premier Global Infrastructure Trust PLC (PGIT.L)'s score of 0.00 indicating that RTW Biotech Opportunities is being referred to more favorably in the media.

RTW Biotech Opportunities has higher revenue and earnings than Premier Global Infrastructure Trust PLC (PGIT.L). Premier Global Infrastructure Trust PLC (PGIT.L) is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Premier Global Infrastructure Trust PLC (PGIT.L)-£2.54M0.00N/A-£40.70N/A

2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 0.6% of RTW Biotech Opportunities shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

RTW Biotech Opportunities has a net margin of 158.61% compared to Premier Global Infrastructure Trust PLC (PGIT.L)'s net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat Premier Global Infrastructure Trust PLC (PGIT.L)'s return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
Premier Global Infrastructure Trust PLC (PGIT.L) N/A N/A N/A

Summary

RTW Biotech Opportunities beats Premier Global Infrastructure Trust PLC (PGIT.L) on 9 of the 10 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Dunedin Enterprise Investment Trust?

Dunedin Enterprise Investment Trust (LON:DNE) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

Dunedin Enterprise Investment Trust has a beta of 0.46, meaning that its stock price is 54% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

RTW Biotech Opportunities has higher revenue and earnings than Dunedin Enterprise Investment Trust. Dunedin Enterprise Investment Trust is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dunedin Enterprise Investment Trust£1.99M0.00£1.56M£28.41N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

32.6% of Dunedin Enterprise Investment Trust shares are owned by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 68.6% of Dunedin Enterprise Investment Trust shares are owned by insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

RTW Biotech Opportunities has a net margin of 158.61% compared to Dunedin Enterprise Investment Trust's net margin of 74.24%. RTW Biotech Opportunities' return on equity of 36.01% beat Dunedin Enterprise Investment Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Dunedin Enterprise Investment Trust74.24% 3.62% 2.87%
RTW Biotech Opportunities 158.61%36.01%-0.47%

In the previous week, RTW Biotech Opportunities had 2 more articles in the media than Dunedin Enterprise Investment Trust. MarketBeat recorded 2 mentions for RTW Biotech Opportunities and 0 mentions for Dunedin Enterprise Investment Trust. RTW Biotech Opportunities' average media sentiment score of 0.19 beat Dunedin Enterprise Investment Trust's score of 0.00 indicating that RTW Biotech Opportunities is being referred to more favorably in the news media.

Company Overall Sentiment
Dunedin Enterprise Investment Trust Neutral
RTW Biotech Opportunities Neutral

Summary

RTW Biotech Opportunities beats Dunedin Enterprise Investment Trust on 8 of the 12 factors compared between the two stocks.

Get RTW Biotech Opportunities News Delivered to You Automatically

Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RTW vs. The Competition

MetricRTW Biotech OpportunitiesCapital Markets IndustryFinance SectorLON Exchange
Market Cap£7.62M£5.37B£13.89B£2.86B
Dividend YieldN/A7.50%5.95%6.26%
P/E Ratio0.0430.0225.34366.92
Price / Sales0.031,222.46507.4590,001.90
Price / Cash0.3247.9230.3027.89
Price / Book0.013.512.736.33
Net Income£14.09B£417.39M£1.31B£5.89B
7 Day Performance-2.88%-1.80%-1.19%-0.75%
1 Month Performance-8.53%-2.80%-0.93%-0.68%
1 Year Performance56.29%3.70%9.58%19.29%

RTW Biotech Opportunities Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RTW
RTW Biotech Opportunities
N/AGBX 2.36
+1.7%
N/A+54.2%£7.62M£250.89M0.044,971
VSL
VPC Specialty Lending Investments
N/AGBX 11
+8.4%
N/A-34.3%£30.61M-£31.41MN/AN/A
RSE
Riverstone Energy
N/AGBX 585.02
+0.4%
N/A-32.9%£28.21M£26.25MN/AN/A
CIP
CIP Merchant Capital
N/AN/AN/AN/A£27.50M£8.87M3.65N/A
PGIT
Premier Global Infrastructure Trust PLC (PGIT.L)
N/AN/AN/AN/A£26.23M-£2.54MN/AN/A

Related Companies and Tools


This page (LON:RTW) was last updated on 9/15/2026 by MarketBeat.com Staff.
From Our Partners